טוען...
AML transformation after autologous stem cell transplant for multiple myeloma
A 59-year-old male patient was diagnosed as multiple myeloma in 2005 and received chemotherapy consisting of thalidomide, cyclophosphamide, and dexamethasone. The patient subsequently received high-dose melphalan followed by autologous stem cell transplantation and maintenance therapy with thalidomi...
שמור ב:
| הוצא לאור ב: | BMJ Case Rep |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4458618/ https://ncbi.nlm.nih.gov/pubmed/26025976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2015-210024 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|